Glenview, Illinois Clinical Trials

A listing of Glenview, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 121 clinical trials
Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With CVD

This is a pivotal phase 3 study designed to support an indication for the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a)

Novartis Investigative Site
 (4.5 away) Contact site
  • 143 views
  • 17 Sep, 2021
  • +578 other locations
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk

The purpose of this research study is to see if lifestyle changes can protect memory and thinking (cognition) as we age. A recent study in Finland found that a combination of physical and cognitive exercise, diet, and social activity protected cognitive function in healthy older adults who were at increased …

dementia
cognitive impairment
amnesia
cognitive decline
Chicagoland--Advocate Aurora Health
 (4.8 away) Contact site
  • 20 views
  • 09 Sep, 2021
  • +8 other locations
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant Advanced High-Grade Epithelial Ovarian Primary Peritoneal or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

This Phase 3 study is designed to compare the efficacy and safety of mirvetuximab soravtansine vs. investigator's choice chemotherapy in patients with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, whose tumors express a high-level of FR. Patients will be, in the opinion of the Investigator, appropriate …

cancer
platelet count
parp inhibitor
ovarian epithelial carcinoma
folic acid
Illinois Cancer Specialists
 (8.5 away) Contact site
  • 88 views
  • 10 Sep, 2021
  • +156 other locations
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

To evaluate the efficacy of AKCEA-TTR-LRx compared to placebo for 120 weeks in patients with ATTR-CM receiving available standard of care (SoC). For more information, please visit https://www.cardio-ttransform.com/.

Northwestern University
 (7.6 away) Contact site
  • 6 views
  • 08 Sep, 2021
  • +101 other locations
A Study of Baricitinib in Participants With Rheumatoid Arthritis

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).

antirheumatics
DMARD
tumor necrosis factor alpha
body mass index
baricitinib
Center of Robert Hozman
 (6.0 away) Contact site
  • 301 views
  • 12 Sep, 2021
  • +170 other locations
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL Mixed Phenotype Acute Leukemia and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. Inotuzumab …

dexamethasone
calcium
vincristine
cancer
cytarabine
Advocate Children's Hospital-Park Ridge
 (4.5 away) Contact site
  • 44 views
  • 12 Sep, 2021
  • +113 other locations
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

corticosteroids
eosinophil count
severe chronic obstructive pulmonary disease
antibiotics
bronchodilator
Research Site
 (6.7 away) Contact site
  • 838 views
  • 10 Sep, 2021
  • +438 other locations
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal Pancreatic or Colorectal Cancer

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer

Orchard Healthcare Research Inc
 (4.3 away) Contact site
  • 143 views
  • 03 Sep, 2021
  • +192 other locations
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) …

cancer
trastuzumab
estrogen
HER2
breast cancer
Illinois Cancer Specialists - Arlington Heights
 (8.5 away) Contact site
  • 24 views
  • 15 Sep, 2021
  • +234 other locations
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1:1 ratio to endarterectomy versus no endarterectomy and another will …

transient ischemic attack
angiography
endarterectomy
stroke
ischemic attack
Northwestern University
 (7.1 away) Contact site
  • 1024 views
  • 04 Sep, 2021
  • +151 other locations